Carotid Baroreceptor Activation for the Treatment of Resistant Hypertension and Heart Failure (Q37997994)

26 August 2017

title

Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure (English)

1 reference

26 August 2017

Carotid Baroreceptor Activation for the Treatment of Resistant Hypertension and Heart Failure (English)

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

28 December 2024

main subject

arterial hypertension

0 references

heart failure

0 references

baroreflex

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22457242

28 December 2024

1

Michael Doumas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22457242

28 December 2024

Vasilios Papademetriou

series ordinal

4

object named as

Vasilios Papademetriou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22457242

28 December 2024

author name string

Charles Faselis

series ordinal

2

1 reference

26 August 2017

Costas Tsioufis

series ordinal

3

1 reference

26 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22457242

28 December 2024

publication date

1 June 2012

1 reference

26 August 2017

June 2012

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22457242

full work available at URL

28 December 2024

http://link.springer.com/content/pdf/10.1007/s11906-012-0258-7.pdf

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

http://link.springer.com/article/10.1007/s11906-012-0258-7/fulltext.html

28 December 2024

file format

HyperText Markup Language

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

http://link.springer.com/content/pdf/10.1007/s11906-012-0258-7

28 December 2024

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Current Hypertension Reports

28 December 2024

published in

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

238-246

1 reference

Baroreflex stimulation in antihypertensive treatment

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Baroreflex device therapy in the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Electrical stimulation of the carotid sinus for the treatment of resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Chronic Baroreflex Activation: A Potential Therapeutic Approach to Heart Failure With Preserved Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Renal sympathetic denervation: the jury is still out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Renal sympathetic denervation and systemic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Renal sympathetic denervation in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Electrical Carotid Baroreceptor Stimulation in Resistant Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

Benefits from treatment and control of patients with resistant hypertension.

21 January 2018

1 reference

12 December 2020

Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension

1 reference

12 December 2020

Mechanism, effects, and reversal of left ventricular hypertrophy in hypertension

1 reference

12 December 2020

Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension

1 reference

12 December 2020

Pulsatile activation of baroreceptors causes central facilitation of baroreflex

1 reference

12 December 2020

Baroreflex control of sympathetic nerve activity in essential and secondary hypertension

1 reference

12 December 2020

Adrenergic and reflex abnormalities in obesity-related hypertension

1 reference

12 December 2020

Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly

1 reference

12 December 2020

Pathophysiology of resistant hypertension: the role of sympathetic nervous system

1 reference

12 December 2020

Renal sympathetic denervation for refractory hypertension

1 reference

12 December 2020

Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions

1 reference

12 December 2020

Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system

1 reference

12 December 2020

Effects of electrical stimulation of the carotid sinus baroreflex using the Rheos device on ventricular-vascular coupling and myocardial efficiency assessed by pressure-volume relations in non-vagotomized anesthetized dogs

1 reference

12 December 2020

American Journal of Physiology

49

256

H1735

MW Chapleau

1989

1 reference

https://api.crossref.org/works/10.1007/S11906-012-0258-7

28 December 2024

Identifiers

1 reference

26 August 2017

1 reference